Nuveen Asset Management, LLC Logic Bio Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$4.03 - $7.57 $140,880 - $264,632	-34,958 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$6.8 - $9.16 $24,942 - $33,598	3,668 Added 11.72%	34,958 $254,000
Q4 2020 Feb 16, 2021	BUY	$5.29 - $9.1 $8,844 - $15,215	1,672 Added 5.65%	31,290 $239,000
Q3 2020 Nov 16, 2020	BUY	$5.41 - $9.45 $2,553 - $4,460	472 Added 1.62%	29,618 $269,000
Q2 2020 Aug 14, 2020	BUY	$4.25 - $8.46 $44,319 - $88,220	10,428 Added 55.71%	29,146 $246,000
Q2 2019 Aug 15, 2019	BUY	$9.77 - $17.08 $182,874 - $319,703	18,718 New	18,718 $243,000

Ticker LOGC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,962,700
Description
LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.